A  common mineral may provide protection against bladder cancer
According  to results of a study published in the September issue of Cancer  Epidemiology, Biomarkers & Prevention, a journal of the American  Association for Cancer Research, selenium intake is associated with decreased  risk of bladder cancer. 
“The lower the levels of selenium, the higher  the risk of developing bladder cancer,” said lead researcher Núria Malats, M.D.,  Ph.D., leader of the Genetic and Molecular Epidemiology Group, Human Cancer  Genetics Program, Spanish National Cancer Research Center.
Selenium is an  essential micronutrient that is incorporated into about 25 proteins, called  selenoproteins. Most of these selenoproteins are enzymes with antioxidant  properties that prevent cellular damage caused by the by-products of oxygen  metabolism, according to Malats. 
The main dietary sources of this  micronutrient are plant foods grown in selenium-rich soils, animals who graze on  these soils and selenium-enriched products. 
Using data from seven  previously published studies, Malats and colleagues conducted a meta-analysis to  evaluate selenium levels measured in serum and toenails and the risk of  developing bladder cancer. The data included individuals mostly from the United  States, but also from Belgium, Finland and the Netherlands.
The  researchers noted a significant protective effect of selenium, mainly among  women, which they believe may result from gender-specific differences in the  mineral’s accumulation and excretion in women.
“Although our results  suggest a beneficial effect of high selenium intake for bladder cancer risk,  more studies are needed to confirm these findings before an enforcement of high  selenium intake is recommended,” Malats said.
Cancer Epidemiology, Biomarkers &  Prevention Editorial Board Member Elizabeth A. Platz,  Sc.D., M.P.H., said, “these findings provide a valuable lead for what to do  next to understand if there is a role for selenium supplementation in bladder  cancer prevention.”
The next research step is to address the  dose-response relationship. Addressing this relationship is of public health  importance for setting recommended daily intakes for selenium and for targeting  subsets of the population for selenium supplementation, added Platz, who is a  professor in the department of epidemiology at Johns Hopkins Bloomberg School of  Public Health.
Source: AACR
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.